Is Delta-9 THC Good for Sleep?

We explore the full story of Delta-9 for sleep: how it affects sleep stages, the benefits for falling asleep, and crucial safety trade-offs.

Delta-9 THC can help some people fall asleep faster and spend more time in deep sleep on a given night, but the evidence is far less clear-cut than cannabis marketing suggests. A 2025 systematic review and meta-analysis found that cannabis does not consistently change sleep duration, how long it takes to fall asleep, or the proportions of different sleep stages when you look across the full body of research. The picture gets more complicated once you factor in tolerance, withdrawal, dose, and who is using it, which is why the honest answer sits somewhere between “it depends” and “probably not long-term.”

What THC Does to Sleep Stages

When researchers wire people up for polysomnography (the gold-standard sleep study), a single dose of THC before bed tends to do two things: increase slow-wave sleep, the deep, physically restorative phase, and suppress REM sleep, the phase most associated with dreaming. A pilot study using lab-grade polysomnography confirmed that THC increased slow-wave sleep and boosted electrical brain activity across multiple frequency bands during the night. Early research from the 1970s established that THC significantly reduced eye-movement activity during REM sleep and, to a lesser degree, the duration of REM itself.

Those two effects sound like a net win if you struggle with insomnia: you get more of the deep sleep your body craves and less of the lighter, dream-heavy sleep that can leave you feeling restless. But the increase in slow-wave sleep has not appeared in every study. A review in the Journal of Primary Care and Community Health noted that while cannabis can boost deep sleep in some trials, the results are inconsistent, and the effects on REM sleep vary as well. A broader review of human cannabis-sleep studies echoed this unevenness, finding that cannabis was linked to both reduced time to fall asleep and reduced total sleep duration, depending on the study.

The underlying mechanism involves your endocannabinoid system. CB1 receptors, which THC activates directly, play a role in stabilizing non-REM sleep. Animal research has shown that endocannabinoid signaling through CB1 is necessary for the stability of non-REM sleep, though it does not appear to govern sleep homeostasis itself. A pharmacological review noted that altering cannabinoid receptors can promote sleep and reduce the time it takes to fall asleep, but that activating CB1 specifically comes with psychoactive side effects.

Tolerance Builds Quickly

Perhaps the most important thing anyone considering THC for sleep should know is that the benefits erode fast. A study of chronic daily cannabis smokers found that while THC had initial sedating effects, both measured and self-reported nighttime sleep duration decreased slightly but significantly over the course of the study, suggesting tolerance to THC’s sleep-promoting effects developed during continued use. A classic review of cannabis tolerance observed that tolerance to sleep-related effects is acquired and, under optimal conditions, lost rapidly.

And here is the twist with deep sleep specifically. While an initial dose of THC may boost slow-wave sleep, an older controlled study found that after roughly a week of nightly THC use, slow-wave sleep actually decreased and continued to decrease even during the first week after stopping the drug. That finding undercuts the popular idea that nightly THC use preserves deep sleep over time. If anything, prolonged use appears to erode the very benefit that made the first few nights feel so restful.

What Happens When You Stop

Withdrawal-related sleep disruption is one of the most consistent findings in the cannabis-sleep literature. The 2025 meta-analysis specifically noted that stopping active cannabis use was consistently associated with reduced total sleep time, longer time to fall asleep, and rebounds in REM sleep. A systematic review focused on cannabis withdrawal and sleep confirmed that sleep was frequently interrupted during withdrawal, though the exact mechanisms remain unclear.

A sleep-lab study looking at withdrawal in heavy cannabis users found decreased sleep efficiency, less total sleep, increased time to fall asleep, and worse subjective sleep quality during abstinence compared to when participants were actively using cannabis. The REM rebound is particularly vivid: people who stop using THC after regular use often report intense, strange dreams, which makes sense given that REM had been suppressed. For some people, this rebound insomnia and dream intensity creates a cycle where they resume THC to sleep, reinforcing dependence on it.

Clinical Trials on THC for Insomnia

Despite the popularity of cannabis as a sleep aid, randomized controlled trials specifically testing THC (or THC-containing products) for insomnia in otherwise healthy adults are surprisingly few. The trials that do exist, however, offer some encouraging short-term data.

A randomized crossover trial tested a cannabinoid medicine called ZTL-101 (containing THC, CBD, and CBN) against placebo in people with chronic insomnia. The active treatment reduced insomnia severity scores by about 5 points, cut self-reported time to fall asleep by roughly 8 minutes, and increased total sleep time by over an hour by self-report and about half an hour by actigraphy. Participants also reported better sleep quality and feeling more rested on waking.

A second randomized crossover trial tested a medicinal cannabis oil containing both THC and CBD in adults with insomnia. After two weeks on the active oil, 60% of participants no longer met the clinical threshold for insomnia. Midnight melatonin levels rose by about 30% in the treatment group compared to a 20% decline in the placebo group. Sleep quality improved by up to 80% on active treatment, and participants reported better daytime functioning.

These are real results, but both trials were short (two weeks of active treatment), used combination products rather than pure THC, and enrolled relatively small groups. Whether those improvements hold over months or years is unknown, and the tolerance data described earlier suggests they might not.

PTSD Nightmares and Sleep Apnea

Two specialized sleep problems show more targeted promise for THC. People with post-traumatic stress disorder often experience severe, recurring nightmares that fragment their sleep and maintain a cycle of hyperarousal. THC and its synthetic analogue nabilone have been found to reliably reduce both the intensity and frequency of PTSD-related nightmares. A small open-label pilot study of oral THC in chronic PTSD patients found improvements in global symptom severity, sleep quality, nightmare frequency, and hyperarousal symptoms. The mechanism likely ties back to REM suppression: less REM means fewer windows for nightmares to occur. This is a case where the sleep-architecture shift that might be a drawback for the general population is actually therapeutic.

Sleep apnea is a different story. Dronabinol, a synthetic form of THC, was tested in a randomized trial for obstructive sleep apnea and reduced breathing-interruption events by about 10 to 13 events per hour compared to placebo, depending on dose. That is a meaningful reduction, though dronabinol is not currently approved for this indication, and the trial was more proof-of-concept than a definitive clinical recommendation.

Dose Matters More Than Most People Realize

THC’s effects on sleep appear to be biphasic: low doses tend to be sedating, while higher doses can actually increase wakefulness and anxiety, which obviously work against sleep. A scoping review documented this pattern across pain, sleep, and anxiety outcomes, noting that dose-response relationships are present but that the literature has significant gaps regarding where the inflection point falls for different people.

Interestingly, a study that gave young adults 15 mg of pure THC found no measurable effect on nocturnal sleep at all. But when THC was combined with CBD at higher doses (15 mg of each), participants showed increased wakefulness and reduced deep sleep. That finding complicates the popular assumption that adding CBD to THC simply enhances the sleep benefit. CBD at higher doses may have a mild activating effect. Clinical data from Sativex (a cannabis-based medicine with roughly equal THC and CBD) showed slight residual sedation from THC-predominant extracts but mild activation from CBD, alongside broad improvements in subjective sleep among patients with chronic pain conditions.

The practical takeaway is that “more THC equals better sleep” is not how it works. People who use edibles and accidentally overshoot their dose often report racing thoughts, anxiety, and worse sleep than if they had taken nothing at all. The therapeutic window for sleep appears to be relatively narrow, and it is different for everyone.

The Morning After

A common concern with any sleep aid is next-day grogginess. The evidence here is mixed. A systematic review of “next day” effects found that a small number of lower-quality studies observed cognitive and performance impairments the morning after THC use, but higher-quality studies and the majority of performance tests did not find significant impairment. An older study found only weak evidence of behavioral or subjective effects the day after moderate doses of marijuana.

However, another older controlled study did find residual “hangover” effects the morning after marijuana smoking, including changes in subjective experience and time perception roughly nine hours after the dose. These hangover effects were different from the acute effects of marijuana, not simply a continuation of being high. A large survey comparing cannabis users’ self-reports with those who use over-the-counter and prescription sleep aids found that cannabis users were more likely to feel refreshed, focused, and better able to function the next morning compared to OTC or prescription alternatives. But they were also more likely to report feeling sleepy, anxious, and irritable, along with side effects like red eyes and thirst.

So the morning-after picture is not dramatically different from other sleep aids. You trade one set of side effects for another. People who use cannabis for sleep tend to prefer it over alternatives, but that preference may be influenced by factors beyond pure pharmacology.

Who Should Be Especially Careful

Older adults are increasingly turning to cannabis for sleep, but the evidence base barely includes them. A review of medical cannabis for older patients pointed out that almost all study participants in the cannabis literature are under 60, while the risk of adverse effects is considerable in older adults, with specific concerns around cognitive function, cardiovascular health, and balance. A small survey from a geriatrics clinic found that about 70% of older patients using cannabis for sleep found it somewhat or extremely helpful, but the sample was tiny, and only three patients reported side effects, including anxiety, panic, paranoia, and dizziness. The gap between patient enthusiasm and clinical evidence is wide here. Falls are already a leading cause of injury in older adults, and THC’s effects on balance and coordination, even at low doses, make this a real concern.

Sex differences also deserve attention. A study comparing cannabis users and non-users found that female cannabis users had significantly poorer sleep quality than male users, non-using females, and non-using males. Women who started using cannabis at a younger age were particularly likely to report sleep problems, a pattern that was not seen in men. The reasons are not fully understood, but the finding is worth noting since most cannabis-sleep research has been conducted predominantly on male participants, and results may not translate equally.

The CBN Myth

Walk into any dispensary and you will find products marketed as sleep-specific formulations featuring CBN (cannabinol) alongside THC. The marketing pitch is that CBN is “the sleepy cannabinoid.” The evidence tells a different story. A review specifically examining the science behind CBN and sleep found that the human research is dated, limited, and overwhelmingly from the 1970s and 1980s with small, demographically narrow samples. The review could not find any published clinical trials linking CBN to validated sleep questionnaires or formal sleep studies, and concluded that there is insufficient evidence to support sleep-related claims for CBN.

The reputation of CBN as a sedative likely comes from the observation that aged cannabis, which has higher CBN content due to THC degradation, tends to feel sleepier. But aged cannabis also contains different terpene profiles and other degradation products, so attributing the effect to CBN specifically is a leap the science has not taken. If you are buying a sleep gummy because it lists CBN on the label, you are paying a premium for a marketing claim that currently has no rigorous backing.

The Variability Problem

One reason the research is so inconsistent is that “THC for sleep” is not one thing. It varies by dose, by route (smoked, vaped, edible, tincture), by cannabinoid ratio (pure THC vs. THC plus CBD), by whether the person is a naive user or a daily consumer, and by whether they have an underlying condition like chronic pain or PTSD. The 2025 meta-analysis emphasized that variability in outcomes across studies reflects the influence of dosage, cannabinoid composition, prior cannabis use, and health conditions. Many earlier studies used high THC doses administered to young male volunteers in a lab, which tells us very little about a middle-aged woman taking a low-dose edible at home.

Delivery method matters for timing. Smoked or vaped THC reaches peak blood levels within minutes and clears relatively quickly, which can help with falling asleep but may not sustain effects through the night. Edibles take 30 minutes to two hours to kick in and produce a longer, more gradual effect, which may better support staying asleep but increases the risk of morning grogginess if the dose is too high or taken too late. These pharmacokinetic differences mean that the same milligram dose can produce very different sleep experiences depending on how you take it.

For someone with chronic pain who cannot sleep because of discomfort, THC may provide a genuine two-for-one benefit: less pain and easier sleep. Large-scale clinical experience with Sativex showed marked improvement in subjective sleep across patients with conditions like neuropathic pain, cancer pain, and rheumatoid arthritis. Whether the sleep improvement was a direct pharmacological effect or a downstream result of reduced pain (or both) is hard to disentangle, but for the person lying awake hurting, the distinction may not matter much.